Plasma plant sterols serve as poor markers of cholesterol absorption in man

Journal of Lipid Research

Volumn 54, Issue 4, 2013, Pages 1144-1150

  Jakulj, Lily ^a   Mohammed, Hussein ^b   Van Dijk, Theo H ^c   Boer, Theo ^c   Turner, Scott ^b   Groen, Albert K ^c   Vissers, Maud N ^a   Stroes, Erik S G ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b KINEMED INC   (United States)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Campesterol; Intestine; Phytosterols; Stable isotopes

Indexed keywords

BIOLOGICAL MARKER; CAMPESTEROL; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LATHOSTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SITOSTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; CHOLESTEROL METABOLISM; DIETARY INTAKE; ENZYME ACTIVITY; ENZYME REGULATION; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; LIPID ABSORPTION; LIPID BLOOD LEVEL; MALE; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

CHOLESTEROL; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INTESTINAL ABSORPTION; MALE; MIDDLE AGED; PHYTOSTEROLS; TRIGLYCERIDES;

EID: 84875829455     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.P031021     Document Type: Article

References (54)

1. Grundy, S. M. 1983. Absorption and metabolism of dietary cholesterol . Annu. Rev. Nutr. 3 : 71-96.
2. Bosner, M. S., L. G. Lange, W. F. Stenson, and R. E. Ostlund, Jr. 1999. Percent cholesterol absorption in normal women and men quantifi ed with dual stable isotopic tracers and negative ion mass spectrometry. J. Lipid Res. 40 : 302-308.
3. Matthan, N. R., and A. H. Lichtenstein. 2004. Approaches to measuring cholesterol absorption in humans. Atherosclerosis. 174 : 197-205.
4. Mackay, D., and P. J. Jones. 2011. Evaluation of methods for the determination of cholesterol absorption and synthesis in humans. Atherosclerosis. 218 : 253-262.
5. Tilvis, R. S., and T. A. Miettinen. 1986. Serum plant sterols and their relation to cholesterol absorption. Am. J. Clin. Nutr. 43 : 92-97.
6. Miettinen, T. A., R. S. Tilvis, and Y. A. Kesäniemi. 1989. Serum cholestanol and plant sterol levels in relation to cholesterol metabolism in middle-Aged men. Metabolism. 38 : 136-140.
7. Bjorkhem, I., T. Miettinen, E. Reihnér, S. Ewerth, B. Angelin, and K. Einarsson. 1987. Correlation between serum levels of some cholesterol precursors and activity of HMG-CoA reductase in human liver. J. Lipid Res. 28 : 1137-1143.
8. Kempen, H. J., J. F. Glatz, J. A. Gevers Leuven, H. A. van der Voort, and M. B. Katan. 1988. Serum lathosterol is an indicator of wholebody cholesterol synthesis in humans. J. Lipid Res. 29 : 1149-1155.
9. Vuoristo, M., and T. A. Miettinen. 1986. Serum cholesterol precursor sterols in coeliac disease: effects of gluten free diet and cholestyramine. Gut. 27 : 1312-1319.
10. Matthan, N. R., M. Raeini-Sarjaz, A. H. Lichtenstein, L. M. Ausman, and P. J. Jones. 2000. Deuterium uptake and plasma cholesterol precursor levels correspond as methods for measurement of endogenous cholesterol synthesis in hypercholesterolemic women. Lipids. 35 : 1037-1044.
11. Jones, P. J., A. S. Pappu, D. R. Illingworth, and C. A. Leitch. 1992. Correspondence between plasma mevalonic acid levels and deuterium uptake in measuring human cholesterol synthesis. Eur. J. Clin. Invest. 22 : 609-613.
12. Miettinen, T. A., R. S. Tilvis, and Y. A. Kesäniemi. 1990. Serum plant sterols and cholesterol precursors refl ect cholesterol absorption and synthesis in volunteers of a randomly selected male population . Am. J. Epidemiol. 131 : 20-31.
13. Miettinen, T. A., H. Gylling, and M. J. Nissinen. 2011. The role of serum non-cholesterol sterols as surrogate markers of absolute cholesterol synthesis and absorption. Nutr. Metab. Cardiovasc. Dis. 21 : 765-769.
14. Paramsothy, P., R. H. Knopp, S. E. Kahn, B. M. Retzlaff, B. Fish, L. Ma, and R. E. Ostlund, Jr. 2011. Plasma sterol evidence for decreased absorption and increased synthesis of cholesterol in insulin resistance and obesity. Am. J. Clin. Nutr. 94 : 1182-1188.
15. Matthan, N. R., M. Pencina, J. M. LaRocque, P. F. Jacques, R. B. D'Agostino, E. J. Schaefer, and A. H. Lichtenstein. 2009. Alterations in cholesterol absorption/synthesis markers characterize Framingham offspring study participants with CHD. J. Lipid Res. 50 : 1927-1935.
16. van Himbergen, T. M., N. R. Matthan, N. A. Resteghini, S. Otokozawa, M. Ai, E. A. Stein, P. H. Jones, and E. J. Schaefer. 2009. Comparison of the effects of maximal dose atorvastatin and rosuvastatin therapy on cholesterol synthesis and absorption markers. J. Lipid Res. 50 : 730-739.
17. Descamps, O. S., J. De Sutter, M. Guillaume, and L. Missault. 2011. Where does the interplay between cholesterol absorption and synthesis in the context of statin and/or ezetimibe treatment stand today? Atherosclerosis. 217 : 308-321.
18. Miettinen, T. A., and H. Gylling. 2005. Effect of statins on noncholesterol sterol levels: implications for use of plant stanols and sterols. Am. J. Cardiol. 96 (1A) : 40D-46D.
19. Hoenig, M. R., B. E. Rolfe, and J. H. Campbell. 2006. Cholestanol: a serum marker to guide LDL cholesterol-lowering therapy. Atherosclerosis. 184 : 247-254.
20. Friedewald, W. T., R. I. Levy, and D. S. Fredrickson. 1972. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18 : 499-502.
21. Jakulj, L., M. N. Vissers, M. W. Tanck, B. A. Hutten, F. Stellaard, J. J. Kastelein, and G. M. Dallinga-Thie. 2010. ABCG5/G8 polymorphisms and markers of cholesterol metabolism: systematic review and meta-Analysis. J. Lipid Res. 51 : 3016-3023.
22. Lee, W. N., L. O. Byerley, E. A. Bergner, and J. Edmond. 1991. Mass isotopomer analysis: theoretical and practical considerations. Biol. Mass Spectrom. 20 : 451-458.
23. Gylling, H., and T. A. Miettinen. 2002. Inheritance of cholesterol metabolism of probands with high or low cholesterol absorption. J. Lipid Res. 43 : 1472-1476.
24. Berge, K. E., K. von Bergmann, D. Lutjohann, R. Guerra, S. M. Grundy, H. H. Hobbs, and J. C. Cohen. 2002. Heritability of plasma noncholesterol sterols and relationship to DNA sequence polymorphism in ABCG5 and ABCG8. J. Lipid Res. 43 : 486-494.
25. Stranberg, T. E., V. Salomaa, H. Vanhanen, and T. A. Miettinen. 1996. Associations of fasting blood glucose with cholesterol absorption and synthesis in nondiabetic middle-Aged men. Diabetes. 45 : 755-761.
26. Miettinen, T. A., and H. Gylling. 2000. Cholesterol absorption effi ciency and sterol metabolism in obesity. Atherosclerosis. 153 : 241-248.
27. Gremaud, G., E. Dalan, C. Piguet, M. Baumgartner, P. Ballabeni, B. Decarli, M. E. Leser, A. Berger, and L. B. Fay. 2002. Effects of non-esterifi ed stanols in a liquid emulsion on cholesterol absorption and synthesis in hypercholesterolemic men. Eur. J. Nutr. 41 : 54-60.
28. Gylling, G., M. Hallikainen, R. A. Rajaratnam, P. Simonen, J. Pihlajamäki, M. Laakso, and T. A. Miettinen. 2009. The metabolism of plant sterols is disturbed in postmenopausal women with coronary artery disease. Metabolism. 58 : 401-407.
29. Merkens, L. S., J. M. Jordan, J. A. Penfi eld, D. Lütjohann, W. E. Connor, and R. D. Steiner. 2009. Plasma plant sterol levels do not refl ect cholesterol absorption in children with Smith-Lemli-Opitz syndrome. J. Pediatr. 154 : 557-561.
30. Ostlund, R. E., Jr. 2002. Phytosterols in human nutrition. Annu. Rev. Nutr. 22 : 533-549.
31. Chan, Y. M., K. A. Varady, Y. Lin, E. Trautwein, R. P. Mensink, J. Plat, and P. J. Jones. 2006. Plasma concentrations of plant sterols: physiology and relationship with coronary heart disease. Nutr. Rev. 64 : 385-402.
32. Ooi, E. M., T. W. Ng, D. C. Chan, and G. F. Watts. 2009. Plasma markers of cholesterol homeostasis in metabolic syndrome subjects with or without type-2 diabetes. Diabetes Res. Clin. Pract. 85 : 310-316.
33. Pihlajamäki, J., H. Gylling, T. A. Miettinen, and M. Laakso. 2004. Insulin resistance is associated with increased cholesterol synthesis and decreased cholesterol absorption in normoglycemic men. J. Lipid Res. 45 : 507-512.
34. Miettinen, T. A., T. E. Strandberg, and H. Gylling. 2000. Noncholesterol sterols and cholesterol lowering by long-term simvastatin treatment in coronary patients: relation to basal serum cholestanol. Arterioscler. Thromb. Vasc. Biol. 20 : 1340-1346.
35. Pinedo, S., M. N. Vissers, K. von Bergmann, K. Elharchaoui, D. Lütjohann, R. Luben, N. J. Wareham, J. J. Kastelein, K. T. Khaw, and S. M. Boekholdt. 2007. Plasma levels of plant sterols and the risk of coronary artery disease: the prospective EPIC-Norfolk Population Study. J. Lipid Res. 48 : 139-144.
36. Pouteau, E., C. Piguet-Welsch, A. Berger, and L. B. Fay. 2003. Determination of cholesterol absorption in humans: from radiolabel to stable isotope studies. Isotopes Environ. Health Stud. 39 : 247-257.
37. Vuoristo, M., and T. A. Miettinen. 1994. Absorption, metabolism, and serum concentrations of cholesterol in vegetarians: effects of cholesterol feeding. Am. J. Clin. Nutr. 59 : 1325-1331.
38. Igel, M., U. Giesa, D. Lutjohann, and K. von Bergmann. 2003. Comparison of the intestinal uptake of cholesterol, plant sterols and stanols in mice. J. Lipid Res. 44 : 533-538.
39. Field, F. J., E. Born, and S. N. Mathur. 2004. LXR/RXR ligand activation enhances basolateral effl ux of beta-sitosterol in CaCo-2 cells. J. Lipid Res. 45 : 905-913.
40. Plösch, T., V. W. Bloks, Y. Terasawa, S. Berdy, K. Siegler, F. Van der Sluijs, I. P. Kema, A. K. Groen, B. Shan, F. Kuipers, et al. 2004. Sitosterolemia in ABC-transporter G5-defi cient mice is aggravated on activation of the liver-X receptor. Gastroenterology. 126 : 290-300.
41. Relas, H., H. Gylling, and T. A. Miettinen. 2001. Fate of intravenously administered squalene and plant sterols in human subjects. J. Lipid Res. 42 : 988-994.
42. Tavani, D. M., W. R. Nes, and J. T. Billheimer. 1982. The sterol substrate specifi city of acyl CoA: cholesterol acyltransferase from rat liver. J. Lipid Res. 23 : 774-781.
43. Salen, G., V. Shore, G. S. Tint, T. Forte, S. Shefer, I. Horak, E. Horak, B. Dayal, L. Nguyen, and A. K. Batta. 1989. Increased sitosterol absorption, decreased removal, and expanded body pools compensate for reduced cholesterol synthesis in sitosterolemia with xanthomatosis. J. Lipid Res. 30 : 1319-1330.
44. Glueck, C. J., J. Speirs, T. Tracy, P. Streicher, E. Illig, and J. Vandegrift. 1991. Relationships of serum plant sterols (phytosterols) and cholesterol in 595 hypercholesterolemic subjects, and familial aggregation of phytosterols, cholesterol, and premature coronary heart disease in hyperphytosterolemic probands and their fi rst-degree relatives. Metabolism. 40 : 842-848.
45. Miettinen, T. A., E. L. Klett, H. Gylling, H. Isoniemi, and S. B. Patel. 2006. Liver transplantation in a patient with sitosterolemia and cirrhosis . Gastroenterology. 130 : 542-547.
46. Vanhanen, H. T., and T. A. Miettinen. 1992. Effects of unsaturated and saturated dietary plant sterols on their serum contents. Clin. Chim. Acta. 205 : 97-107.
47. Naumann, E., J. Plat, and R. P. Mensink. 2003. Changes in serum concentrations of non-cholesterol sterols and lipoproteins in healthy subjects do not depend on the ratio of plant sterols to stanols in the diet. J. Nutr. 133 : 2741-2747.
48. Escurriol, V., M. Cofán, C. Moreno-Iribas, N. Larrañaga, C. Martínez, C. Navarro, L. Rodríguez, C. A. González, D. Corella, and E. Ros. 2010. Phytosterol plasma concentrations and coronary heart disease in the prospective Spanish EPIC cohort. J. Lipid Res. 51 : 618-624.
49. Salen, G., E. H. Ahrens, Jr. ., and S. M. Grundy. 1970. Metabolism of beta-sitosterol in man. J. Clin. Invest. 49 : 952-967.
50. Teupser, D., R. Baber, U. Ceglarek, M. Scholz, T. Illig, C. Gieger, L. M. Holdt, A. Leichtle, K. H. Greiser, D. Huster, et al. 2010. Genetic regulation of serum phytosterol levels and risk of coronary artery disease. Circ. Cardiovasc. Genet. 3 : 331-339.
51. Kempen, H. J., P. de Knijff, D. I. Boomsma, H. A. van der Voort, J. A. Gevers Leuven, and L. Havekes. 1991. Plasma levels of lathosterol and phytosterols in relation to age, sex, anthropometric parameters, plasma lipids, and apolipoprotein E phenotype, in 160 Dutch families. Metabolism. 40 : 604-611.
52. Klasen, E. C., M. Smit, P. de Kniff, J. Gevers Leuven, R. Kempen-Voogd, and L. Havekes. 1987. Apolipoprotein E phenotype and gene distribution in The Netherlands. Hum. Hered. 37 : 340-344.
53. Wu, K., R. Bowman, A. A. Welch, R. N. Luben, N. Wareham, K. T. Khaw, and S. A. Bingham. 2007. Apolipoprotein E polymorphisms, dietary fat and fi bre, and serum lipids: the EPIC Norfolk study. Eur. Heart J. 28 : 2930-2936.
54. Simonen, P., H. Gylling, A. N. Howard, and T. A. Miettinen. 2000. Introducing a new component of the metabolic syndrome: low cholesterol absorption. Am. J. Clin. Nutr. 72 : 82-88.